Advisors Preferred, LLC Calliditas Therapeutics Ab Transaction History
Advisors Preferred, LLC
- $645 Million
- Q3 2024
A detailed history of Advisors Preferred, LLC transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Advisors Preferred, LLC holds 2,022 shares of CALT stock, worth $80,880. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,022Holding current value
$80,880% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CALT
# of Institutions
6Shares Held
20.3KCall Options Held
0Put Options Held
0-
Crossmark Global Holdings, Inc.16.1KShares$644,6800.01% of portfolio
-
Simplex Trading, LLC1.83KShares$73,0400.0% of portfolio
-
Rhumbline Advisers Boston, MA303Shares$12,1200.0% of portfolio
-
Missouri Trust & Investment CO Springfield, MO35Shares$1,4000.0% of portfolio
-
Nalls Sherbakoff Group, LLC Knoxville, TN18Shares$7200.0% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...